Lower extremity atherosclerotic obliterans (LEASO) is part of atherosclerosis and is more common in patients with long-term underlying chronic diseases, including hypertension, diabetes, hyperlipidemia, especially in patients with unwell control of blood pressure, blood sugar, and blood lipids.
Conditions
Interventions
control group:none
Observation group:none
Sponsors
Beijing Friendship Hospital Pinggu Campus,Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Age >=18 years old; 2.Before this treatment, no surgical treatment or intravascular treatment was received for lower limb arteries. 3.Complete at least 1 year of follow-up after surgery; 4.During the postoperative follow-up period, you should take statin, aspirin and other drugs for at least 1 year. 5.Clinical data are complete.
Exclusion criteria
Exclusion criteria: 1.Combined with malignant tumors, rheumatoid immune diseases; 2.Lower limb trauma, orthopedic surgery, etc. occurred during the follow-up period; 3.Death during 1 year of follow-up, but the progress of lower limb artery lesions was unclear; 4.Patients with stent implantation have stent fractures, dislocations, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of restenosis of target lesions during 1-year follow-up; | — |
Secondary
| Measure | Time frame |
|---|---|
| Biochemical indicators(Total cholesterol, LDL cholesterol, alanine aminotransferase, creatinine); | — |
Countries
China
Contacts
Public ContactChun Zhou
Beijing Friendship Hospital Pinggu Campus,Capital Medical University
Outcome results
None listed